- Biopharmaceutical industries get access to streamlined development and production processes for peptide- or protein-based biologicals. - Health systems benefit from the availability of enhanced or decentralised production systems for innovative health technologies that involve peptides or proteins, and which improve health and care. - Citizens and patients will benefit from better access, availability and affordability of pharmaceuticals based on biologicals.
The conditions for qualifying. An eligibility check tests your details against each one.
At least 3 independent partners
Does your company qualify?
Give a few facts about your company and project, and see for each condition whether you meet it.
Eligibility checkThe EIC STEP Scale Up call offers a total indicative budget of EUR 300 million for 2026, which is expected to rise to EUR 900 million for the period 2025-2027. Any unused amount from this b…
The EIC Accelerator supports companies (principally SMEs, including start-ups) to scale up high impact innovations with the potential to create new markets or disrupt existing ones. The EIC…
Grant from SBEP (EU-funded project) across the EU. Total budget €37,723,260. Applications until 16 November 2026.
A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.